Results 181 to 190 of about 25,422 (300)

Bioclimatic Reorganization of Carbon–Water–Energy Coupling Revealed by Eddy Covariance and Interpretable Machine Learning

open access: yesGlobal Change Biology Communications, Volume 1, Issue 2, June 2026.
Ecosystem carbon, water, and energy exchange reorganize systematically along climatic gradients from humid to dry conditions. Tapering shapes indicate shifts in the relative importance of environmental drivers and ecosystem fluxes across climate space, with thicker ends representing greater influence or magnitude.
Koong Yi   +21 more
wiley   +1 more source

Climate Controls on Carbon Dioxide Fluxes in a High‐Elevation Grassland

open access: yesGlobal Change Biology Communications, Volume 1, Issue 2, June 2026.
Climate change is significantly influencing high‐elevation grasslands, possibly unbalancing CO2 exchanges and the sink‐source dynamics. Cumulated heat available for plant growth and vegetation cover were identified as the main controllers of phenological development and, via direct or mediated effects, of CO2 fluxes (ER and GPP).
Silvio Marta   +11 more
wiley   +1 more source

Photorespiration as a Thermal Protection Mechanism in Trees: Measurements, Assumptions, and Persistent Gaps

open access: yesGlobal Change Biology Communications, Volume 1, Issue 2, June 2026.
Conceptual framework linking leaf‐level photorespiratory biochemistry to global‐scale uncertainty in carbon cycle modelling. Rubisco acts as a temperature‐sensitive biochemical switch: At optimal temperatures (~25°C) carboxylation dominates and drives biomass accumulation, whereas heat stress (> 35°C) favours oxygenation and initiates photorespiration (
Rakesh Tiwari   +2 more
wiley   +1 more source

Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti‐C5 therapy

open access: yesHemaSphere, Volume 10, Issue 6, June 2026.
Abstract Patients with paroxysmal nocturnal hemoglobinuria (PNH) on anti‐C5 often experience extravascular hemolysis with anemia. Iptacopan, the first oral proximal complement inhibitor targeting factor B, has shown efficacy and safety in PNH patients. APPULSE‐PNH (NCT05630001), a phase 3b, single‑arm, open‐label trial, enrolled adult patients with PNH
Austin Kulasekararaj   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy